PSMB9 and nasopharyngeal carcinoma: A recombinant adeno-associated virus, carrying a fusion gene containing EBV LMP1 and LMP2 CTL epitopes and heat shock protein as an adjuvant, has been investigated as a potential vaccine for NPC treatment [95].